Waiving patents for Covid vaccines won't solve the 'need of the hour,' says Indian drugmaker

The world faces an urgent need to vaccinate people, and waiving intellectual property rights doesn't address that problem, according to Umang Vohra of Cipla.

from Health and Science https://ift.tt/33RGvRP
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH